Lisata Therapeutics, Inc. (LSTA) Ownership

NASDAQ: LSTATop holders, insider trades and short interest.

LSTA ownership summary

as of October 17, 2026
Institutions
11.2%
of shares outstanding
Insiders
22.26%
of shares outstanding
Shares outstanding
10.8M
Float
6.8M
shares available to trade
Short interest
0.43%
39K shares short
Days to cover
0.14
short interest down 76.1% vs prior month
  • Institutions 11.24%
  • Insiders 22.26%
  • Other investors 66.50%

LSTA top institutional holders

20 largest
Lisata Therapeutics, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Deeter Investments LLP3.37%364K$375,413+364,479 (0.0%)March 31, 2026
2Vanguard Capital Management, LLC2.58%279K$287,202+7,022 (+2.6%)June 30, 2026
3Yakira Capital Management, Inc.1.28%139K$142,718+138,561 (0.0%)June 30, 2026
4Css LLC1.02%110K$113,735+48,524 (+78.4%)June 30, 2026
5Deltec Asset Management LLC0.77%83K$85,693−6,803 (−7.6%)June 30, 2026
6Geode Capital Management, LLC0.67%73K$74,811+1,745 (+2.5%)June 30, 2026
7Virtu Financial LLC0.54%59K$60,545+16,569 (+39.3%)June 30, 2026
8BlackRock Inc0.51%55K$56,503—June 30, 2026
9Vanguard Fiduciary Trust Co0.45%49K$50,433+14,047 (+40.2%)June 30, 2026
10State Street Corp0.23%25K$26,108—June 30, 2026
11Jane Street Group LLC0.17%19K$19,303+18,741 (0.0%)June 30, 2026
12Citadel Advisors Llc0.14%16K$16,007−7,125 (−31.4%)June 30, 2026
13Northern Trust Corp0.14%16K$16,000+5,266 (+51.3%)June 30, 2026
14JBF Capital, Inc.0.13%14K$14,777+1,113 (+8.4%)June 30, 2026
15HPM Partners LLC0.11%12K$12,548—June 30, 2026
16SOL Capital Management Co0.11%12K$12,540+12,175 (0.0%)March 31, 2026
17Bank of America Corp0.10%10K$10,664—June 30, 2026
18HighTower Advisors, LLC0.09%10K$10,343—June 30, 2026
19International Assets Investment Management, LLC0.05%5,000$5,150—June 30, 2026
20Founders Capital Management Inc0.02%1,667$1,717—June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 628K shares and 2 cut 14K.

LSTA top mutual fund and ETF holders

10 largest
Lisata Therapeutics, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest1.77%191K$197,112—August 31, 2026
2Fidelity Extended Market Index0.35%38K$39,212−205 (−0.5%)August 31, 2026
3Fidelity Series Total Market Index0.10%10K$10,684—August 31, 2026
4Vanguard Balanced Index Inv0.07%7,022$7,233—August 31, 2026
5Fidelity Nasdaq Composite Index0.04%4,427$4,560—August 31, 2026
6Fidelity Total Market Index0.04%4,379$4,510—August 31, 2026
7DFA US Social Core Equity 2 Portfolio0.02%2,185$2,251—August 31, 2026
8Vanguard U.S. Eq Idx £ Acc0.01%1,033$1,064—August 31, 2026
9Dimensional US Sustainability Core 1 ETF<0.01%100$103—September 30, 2026
10Dimensional US Core Equity 1 ETF<0.01%8$8—September 24, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

LSTA shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns LSTA

Institutional investors own 11.2% of Lisata Therapeutics's shares and insiders 22.26%. The largest holder is Deeter Investments LLP with 3.37% of the shares (364K), as of March 31, 2026. Among the top 20 institutions, 11 added shares and 2 reduced their stake in the latest filings. Short interest is 0.43% of the float, or 0.14 days of average trading volume. The share count rose 3,877.6% since 2014.

Related: LSTA analyst forecast, LSTA key metrics. See the LSTA stock overview for the latest quote and news.

LSTA ownership FAQ

Who owns the most Lisata Therapeutics stock?

The largest shareholders of Lisata Therapeutics are Deeter Investments LLP (3.37%), Vanguard Capital Management, LLC (2.58%), Yakira Capital Management, Inc. (1.28%), Css LLC (1.02%), Deltec Asset Management LLC (0.77%).

What percentage of Lisata Therapeutics is owned by institutions?

Institutions hold 11.2% of Lisata Therapeutics's shares outstanding; insiders hold 22.26%.

Which funds own Lisata Therapeutics?

The largest fund holders of Lisata Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (1.77%), Fidelity Extended Market Index (0.35%), Fidelity Series Total Market Index (0.10%), Vanguard Balanced Index Inv (0.07%), Fidelity Nasdaq Composite Index (0.04%).

What is Lisata Therapeutics's short interest?

39K shares of Lisata Therapeutics were sold short, 0.43% of the float; at the average daily volume it would take 0.14 days to cover.

How many shares of Lisata Therapeutics are outstanding?

Lisata Therapeutics has 10.8M shares outstanding, of which 6.8M are in the public float.

Biotechnology: ownership